Articles

Podcasts

Videos

Psychiatry

Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.

Patients treated with LAIAs had a lower risk of hospitalization for any cause, hospitalizations for psychiatric disorders, hospitalizations for schizophrenia, and incident suicide attempts compared to patients treated with oral antipsychotics.

Long-Acting Injectables Reduce Disease Relapse in Schizophrenia

Investigators confirmed olanzapine and samidorphan (LYBALVI) resulted in statistically significant less weight gain compared to patients with schizophrenia between 16-39 years treated with olanzapine.

Rene Kahn, MD: Leveling Off Weight Gain in Schizophrenia Treatment

Lois Choi-Kain, MD, MEd, discusses her field's interest in improving the modern diagnosis and evidenced-based treatment of personality disorders.

The New Era of Borderline Personality Disorder Care

A 6-year mirror analysis of risperidone, once-monthly paliperidone palmitate or once-monthly aripiprazole concludes suggesting the regimens may serve as an alternative to clozapine.

Second-Generation Long-Acting Injectables Significantly Improve Long-Term Severe Schizophrenia Outcomes

The treatment represents the only FDA approved orally dissolving sublingual film for this patient population. 

FDA Approves Dexmedetomidine for Adults with Schizophrenia or Bipolar Disorder

Clinical decision support intervention resulted in a rate of change in total modifiable CV risk that was 4% lower among intervention patients compared to control. 

Clinical Decision Support Lowers CV Risk in Patients with Serious Mental Illness  

Melatonin is seen as the most promising treatment in this patient population.

More Research Needed on Sleep Issues for Postmenopausal Women With Schizophrenia

The treatment met the pre-specified primary endpoint of significantly less weight gain in the ENLIGHTEN-Early trial.

Olanzapine and Samidoprhan Combination Reduces Weight Gain Risk for Schizophrenia Patients

There was an elevated risk of violence perpetration in both men and women with schizophrenia spectrum disorder.

Perpetrating Violent Outcomes Risk Increased for Schizophrenia Patients 

Ineligible patients with schizophrenia have a higher risk of hospitalization for a number of reasons, including suicide attempts.

Making Sense of Trial Eligibility for Schizophrenia Studies

The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.

Schizophrenia

Latest News